Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Unapproved Drugs Initiative Comes Back To Life, With New Enforcement Guidance On Its Way
May 26 2021
•
By
Sue Sutter
FDA may modify its unapproved drugs initiative as the agency revives it. • Source: Photo illustration/Alamy image
More from Compliance
More from Pink Sheet